side effects Tagged Articles
Medical groups want children to have their cholesterol levels checked
Children ages 9-11 should have their cholesterol levels checked by their pediatricians, recommends the National Heart, Lung and Blood Institute.
Controversy surrounds upcoming FDA decision on long-acting testosterone drug
The Food and Drug Administration (FDA) is expected to decide this week the fate of a long-acting testosterone product made by Endo Health Solutions, Inc. Aveed, indicated to boost testosterone in men with low levels of the hormone, has been
Once-weekly injectable type 2 diabetes treatment just as effective as Victoza
Dulaglutide, an experimental once-weekly injectable treatment for type 2 diabetes, works just as well as the daily injectable drug Victoza (liraglutide), according to a new data from a clinical trial pitting the two diabetes drugs against each other. Even though
Doctors, addiction experts urge FDA not to allow sales of potent new painkilling opioid Zohydro
More than 40 health care, consumer and addiction treatment groups have teamed up to urge drug regulators to rethink the approval of the potent painkiller Zohydro ER, due to hit the market in March.
Contaminated, mislabeled or unlabeled vials of general anesthesia recalled
Small back particles identified as paper shipper labels floating in vials of an injectable general anesthesia has led to a recall of some lots of Pfizer-Mylan’s Etomidate Injection. The intravenous administration of particles may lead to impairment of microcirculation, phlebitis, infection,
Testing reveals genetic disorder treatment contains wrong drug ingredient
A Food and Drug Administration (FDA) analysis of recalled lots of Medisca’s L-citrulline, a drug used to treat certain urea cycle disorders, a rare genetic disorder primarily diagnosed in children, revealed that the samples contained N-acetyl-leucine, a product used to
UK advisors propose wider indication for cholesterol-lowering statins
The National Institute for Health and Care Excellence (NICE) has released a draft guidance on the management of high cholesterol for people with and without cardiovascular disease, as well as those with diabetes and chronic kidney disease.
FDA opens investigation into heart failure risk with diabetes drugs Onglyza, Kombiglyze
The Food and Drug Administration (FDA) has opened an investigation into the safety of the type 2 diabetes drug saxagliptin after a recent study published in the New England Journal of Medicine (NEJM), reported an increased rate of hospitalizations for
Testing shows calcium injections were contaminated with dangerous bacteria
The Food and Drug Administration (FDA) is urging health care professionals to follow up with patients treated with injections of calcium gluconate 10% made by Rx Formulations between Nov. 7 and Dec. 11, 2013. Testing on the product has confirmed
Pfizer’s experimental breast cancer drug shows promising results in mid-stage trial
A new breast cancer drug is showing promising results in mid-stage clinical trials, currently leading the way for a new standard of treatment for the disease.